BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 24942956)

  • 21. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
    Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
    Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis.
    Bonelli M; von Dalwigk K; Savitskaya A; Smolen JS; Scheinecker C
    Ann Rheum Dis; 2008 May; 67(5):664-71. PubMed ID: 17728327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IgM antibodies against phosphorylcholine promote polarization of T regulatory cells from patients with atherosclerotic plaques, systemic lupus erythematosus and healthy donors.
    Sun J; Lundström SL; Zhang B; Zubarev RA; Steuer J; Gillgren P; Rahman M; Ajeganova S; Liu A; Frostegård J
    Atherosclerosis; 2018 Jan; 268():36-48. PubMed ID: 29175653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4+CD25+ regulatory T cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroids.
    Azab NA; Bassyouni IH; Emad Y; Abd El-Wahab GA; Hamdy G; Mashahit MA
    Clin Immunol; 2008 May; 127(2):151-7. PubMed ID: 18299252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunoregulatory effect of bone marrow mesenchymal stem cells on regulatory T cells in patients with systemic lupus erythematosis].
    Sun Y; Zhang FS; Zhang ZY
    Zhonghua Nei Ke Za Zhi; 2007 Dec; 46(12):1018-21. PubMed ID: 18478921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myeloid-Derived Suppressor Cells Induce the Expansion of Regulatory B Cells and Ameliorate Autoimmunity in the Sanroque Mouse Model of Systemic Lupus Erythematosus.
    Park MJ; Lee SH; Kim EK; Lee EJ; Park SH; Kwok SK; Cho ML
    Arthritis Rheumatol; 2016 Nov; 68(11):2717-2727. PubMed ID: 27214349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Suppressor hyperactivity in relation to allogeneic lymphocyte proliferation as a manifestation of T- T-cell interaction defects in systemic lupus erythematosus].
    Stenina MA; Potapova AA; Biriukov AV; Skripnik AIu; Cheredeev AH
    Biull Eksp Biol Med; 1986 Aug; 102(8):215-7. PubMed ID: 2874848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.
    Dolff S; Wilde B; Patschan S; Dürig J; Specker C; Philipp T; Kribben A; Witzke O
    Scand J Immunol; 2007 Nov; 66(5):584-90. PubMed ID: 17868260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression of regulatory B cells in peripheral blood of patients with systemic lupus erythematosus].
    Cai X; Li X; Lin X; Tang C; Ye J; Li W; He Z; Li F; Xu Y
    Zhonghua Yi Xue Za Zhi; 2015 May; 95(17):1310-3. PubMed ID: 26081660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunomodulation of human CD19
    Hong M; Liao Y; Liang J; Chen X; Li S; Liu W; Gao C; Zhong Z; Kong D; Deng J; Zhang J; Pan G
    Hum Immunol; 2019 Oct; 80(10):863-870. PubMed ID: 31262519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS; Krishnadas DK; Agrawal B
    Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impairment of CD8+ T suppressor cell function in patients with active systemic lupus erythematosus.
    Filaci G; Bacilieri S; Fravega M; Monetti M; Contini P; Ghio M; Setti M; Puppo F; Indiveri F
    J Immunol; 2001 May; 166(10):6452-7. PubMed ID: 11342672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory T cells in patients with systemic lupus erythematosus.
    Alvarado-Sánchez B; Hernández-Castro B; Portales-Pérez D; Baranda L; Layseca-Espinosa E; Abud-Mendoza C; Cubillas-Tejeda AC; González-Amaro R
    J Autoimmun; 2006 Sep; 27(2):110-8. PubMed ID: 16890406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
    Kuhn A; Beissert S; Krammer PH
    Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lower expression levels of the programmed death 1 receptor on CD4+CD25+ T cells and correlation with the PD-1.3A genotype in patients with systemic lupus erythematosus.
    Kristjansdottir H; Steinsson K; Gunnarsson I; Gröndal G; Erlendsson K; Alarcón-Riquelme ME
    Arthritis Rheum; 2010 Jun; 62(6):1702-11. PubMed ID: 20178125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression.
    Stagakis E; Bertsias G; Verginis P; Nakou M; Hatziapostolou M; Kritikos H; Iliopoulos D; Boumpas DT
    Ann Rheum Dis; 2011 Aug; 70(8):1496-506. PubMed ID: 21602271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells.
    Parietti V; Monneaux F; Décossas M; Muller S
    Arthritis Rheum; 2008 Jun; 58(6):1751-61. PubMed ID: 18512811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T follicular helper cells and regulatory B cells dynamics in systemic lupus erythematosus.
    Yang X; Yang J; Chu Y; Xue Y; Xuan D; Zheng S; Zou H
    PLoS One; 2014; 9(2):e88441. PubMed ID: 24551101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus.
    Bijl M; Horst G; Limburg PC; Kallenberg CG
    Ann Rheum Dis; 2001 May; 60(5):523-6. PubMed ID: 11302879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated Expression and Pro-Inflammatory Activity of IL-36 in Patients with Systemic Lupus Erythematosus.
    Chu M; Wong CK; Cai Z; Dong J; Jiao D; Kam NW; Lam CW; Tam LS
    Molecules; 2015 Oct; 20(10):19588-604. PubMed ID: 26516833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.